Network dynamic model of epidemic transmission introducing a heterogeneous control factor.


Journal

Journal of medical virology
ISSN: 1096-9071
Titre abrégé: J Med Virol
Pays: United States
ID NLM: 7705876

Informations de publication

Date de publication:
Dec 2021
Historique:
revised: 05 04 2021
received: 13 10 2020
accepted: 12 04 2021
pubmed: 15 4 2021
medline: 28 10 2021
entrez: 14 4 2021
Statut: ppublish

Résumé

The COVID-19 epidemic is not only a medical issue but also a sophisticated social problem. We propose a network dynamics model of epidemic transmission introducing a heterogeneous control factor. The proposed model applied the classical susceptible- exposed-infectious-recovered model to the network based on effective distance and was modified by introducing a heterogeneous control factor with temporal and spatial characteristics. International aviation data were approximately used to estimate the flux fraction matrix, and the effective distance was calculated. Through parameter estimation and simulation, the theoretical values of the modified model fit well with practical values. By adjusting the parameters and observing the change of the results, we found that the modified model is more in line with the actual needs and has higher credibility in the comprehensive analysis. The assessment shows that the number of confirmed cases worldwide will reach about 20 million optimistically. In severe cases, the peak value will exceed 80 million, and the late stage of the epidemic shows a long tail shape, lasting more than one and a half years. The effective way to control the global epidemic is to strengthen international cooperation and to impose international travel restrictions and other measures.

Identifiants

pubmed: 33851729
doi: 10.1002/jmv.27025
pmc: PMC8250401
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

6496-6505

Informations de copyright

© 2021 Wiley Periodicals LLC.

Références

Acta Trop. 2015 Mar;143:29-35
pubmed: 25559047
Science. 2013 Dec 13;342(6164):1337-42
pubmed: 24337289
N Engl J Med. 2020 Apr 30;382(18):1708-1720
pubmed: 32109013
J Med Virol. 2020 Jul;92(7):841-848
pubmed: 32243599
Nature. 2015 Aug 6;524(7563):65-8
pubmed: 26131931
Int J Infect Dis. 2020 Mar;92:214-217
pubmed: 32007643
Stoch Environ Res Risk Assess. 2020;34(7):959-972
pubmed: 32837309
JCO Oncol Pract. 2022 Apr;18(4):e586-e599
pubmed: 34990292
Infect Dis Poverty. 2020 Feb 28;9(1):24
pubmed: 32111262
J Med Virol. 2021 Dec;93(12):6496-6505
pubmed: 33851729
Proc Natl Acad Sci U S A. 2004 Oct 19;101(42):15124-9
pubmed: 15477600
Commun Nonlinear Sci Numer Simul. 2020 Sep;88:105303
pubmed: 32355435
Nature. 2005 May 12;435(7039):207-11
pubmed: 15889093
Rep Prog Phys. 2017 Mar;80(3):036603
pubmed: 28176679
Appl Intell (Dordr). 2021;51(5):2818-2837
pubmed: 34764566
Comput Methods Programs Biomed. 2020 Nov;196:105642
pubmed: 32688137
Bull Math Biol. 2020 Jul 16;82(7):96
pubmed: 32676740
J Thorac Dis. 2020 Mar;12(3):165-174
pubmed: 32274081
Chaos Solitons Fractals. 2020 Jul;136:109925
pubmed: 32501373
Int J Environ Res Public Health. 2020 Apr 28;17(9):
pubmed: 32353991

Auteurs

Huaxiong Sheng (H)

Graduate School of National Defense University, Beijing, China.

Lin Wu (L)

Joint Operation College of National Defense University, Beijing, China.

Tingting Wu (T)

Graduate School of National Defense University, Beijing, China.

Bo Peng (B)

Joint Operation College of National Defense University, Beijing, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH